152 related articles for article (PubMed ID: 19063699)
1. Topical use of recombinant human thrombin for operative hemostasis.
Anderson CD; Bowman LJ; Chapman WC
Expert Opin Biol Ther; 2009 Jan; 9(1):133-7. PubMed ID: 19063699
[TBL] [Abstract][Full Text] [Related]
2. Topical recombinant human thrombin in surgical hemostasis.
Bowman LJ; Anderson CD; Chapman WC
Semin Thromb Hemost; 2010 Jul; 36(5):477-84. PubMed ID: 20632245
[TBL] [Abstract][Full Text] [Related]
3. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis.
Chapman WC; Singla N; Genyk Y; McNeil JW; Renkens KL; Reynolds TC; Murphy A; Weaver FA
J Am Coll Surg; 2007 Aug; 205(2):256-65. PubMed ID: 17660072
[TBL] [Abstract][Full Text] [Related]
4. A review of three stand-alone topical thrombins for surgical hemostasis.
Cheng CM; Meyer-Massetti C; Kayser SR
Clin Ther; 2009 Jan; 31(1):32-41. PubMed ID: 19243705
[TBL] [Abstract][Full Text] [Related]
5. Preclinical safety of recombinant human thrombin.
Heffernan JK; Ponce RA; Zuckerman LA; Volpone JP; Visich J; Giste EE; Jenkins N; Boster D; Pederson S; Knitter G; Palmer T; Wills M; Early RJ; Rogge MC
Regul Toxicol Pharmacol; 2007 Feb; 47(1):48-58. PubMed ID: 16971028
[TBL] [Abstract][Full Text] [Related]
6. A safety review of topical bovine thrombin-induced generation of antibodies to bovine proteins.
Ofosu FA; Crean S; Reynolds MW
Clin Ther; 2009 Apr; 31(4):679-91. PubMed ID: 19446142
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thrombin: in surgical hemostasis.
Croxtall JD; Scott LJ
BioDrugs; 2009; 23(5):333-8. PubMed ID: 19754221
[TBL] [Abstract][Full Text] [Related]
8. Comparison of recombinant human thrombin and plasma-derived human alpha-thrombin.
Bishop PD; Lewis KB; Schultz J; Walker KM
Semin Thromb Hemost; 2006 Apr; 32 Suppl 1():86-97. PubMed ID: 16673270
[TBL] [Abstract][Full Text] [Related]
9. A phase 3b, open-label, single-group immunogenicity and safety study of topical recombinant thrombin in surgical hemostasis.
Singla NK; Ballard JL; Moneta G; Randleman CD; Renkens KL; Alexander WA
J Am Coll Surg; 2009 Jul; 209(1):68-74. PubMed ID: 19651065
[TBL] [Abstract][Full Text] [Related]
10. Safety and immunogenicity observations pooled from eight clinical trials of recombinant human thrombin.
Ballard JL; Weaver FA; Singla NK; Chapman WC; Alexander WA
J Am Coll Surg; 2010 Feb; 210(2):199-204. PubMed ID: 20113940
[TBL] [Abstract][Full Text] [Related]
11. Topical thrombins: benefits and risks.
Lomax C; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):8S-12S. PubMed ID: 19558279
[TBL] [Abstract][Full Text] [Related]
12. Persistence of antibodies to the topical hemostat bovine thrombin.
Randleman CD; Singla NK; Renkens KL; Souza S; Pribble JP; Alexander WA
J Am Coll Surg; 2010 Dec; 211(6):798-803. PubMed ID: 20980172
[TBL] [Abstract][Full Text] [Related]
13. Prospective, Randomized, Phase II, Non-Inferiority Study to Evaluate the Safety and Efficacy of Topical Thrombin (Human) Grifols as Adjunct to Hemostasis During Vascular, Hepatic, Soft Tissue, and Spinal Open Surgery.
Minkowitz H; Navarro-Puerto J; Lakshman S; Singla S; Cousar C; Kim R; Villavicencio A; Kirksey L; Ayguasanosa J;
J Am Coll Surg; 2019 Nov; 229(5):497-507.e1. PubMed ID: 31376435
[TBL] [Abstract][Full Text] [Related]
14. Immunogenicity and safety of re-exposure to recombinant human thrombin in surgical hemostasis.
Singla NK; Gasparis AP; Ballard JL; Baron JM; Butine MD; Pribble JP; Alexander WA;
J Am Coll Surg; 2011 Dec; 213(6):722-7. PubMed ID: 21958507
[TBL] [Abstract][Full Text] [Related]
15. Bioavailability and relative tissue distribution of [125I]-recombinant human thrombin following intravenous or subcutaneous administration to non-human primates.
Visich JE; Byrnes-Blake KA; Lewis KB; Meengs B; Rogge MC
J Thromb Haemost; 2006 Sep; 4(9):1962-8. PubMed ID: 16796709
[TBL] [Abstract][Full Text] [Related]
16. Immune-mediated coagulopathy associated with topical bovine thrombin: review of the pediatric literature.
Rodgers GM
J Pediatr Hematol Oncol; 2011 Mar; 33(2):86-8. PubMed ID: 21228719
[TBL] [Abstract][Full Text] [Related]
17. Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin.
Ortel TL; Mercer MC; Thames EH; Moore KD; Lawson JH
Ann Surg; 2001 Jan; 233(1):88-96. PubMed ID: 11141230
[TBL] [Abstract][Full Text] [Related]
18. A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures.
Weaver FA; Lew W; Granke K; Yonehiro L; Delange B; Alexander WA;
J Vasc Surg; 2008 Jun; 47(6):1266-73. PubMed ID: 18440754
[TBL] [Abstract][Full Text] [Related]
19. Achieving hemostasis in the surgical field.
Boucher BA; Traub O
Pharmacotherapy; 2009 Jul; 29(7 Pt 2):2S-7S. PubMed ID: 19558278
[TBL] [Abstract][Full Text] [Related]
20. Use of the electrosurgical knife and topical thrombin for hemostasis in split-thickness skin graft vestibuloplasty.
Forman D; Lieblich SE; Berger J; Gold BD
J Oral Maxillofac Surg; 1984 Nov; 42(11):751-2. PubMed ID: 6387072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
